1. Home
  2. KXIN vs ADXN Comparison

KXIN vs ADXN Comparison

Compare KXIN & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KXIN

Kaixin Auto Holdings

HOLD

Current Price

$5.82

Market Cap

3.3M

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$7.99

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KXIN
ADXN
Founded
2015
2002
Country
China
Switzerland
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
10.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KXIN
ADXN
Price
$5.82
$7.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
7.1K
Earning Date
01-01-0001
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$95,000.00
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.94
$6.51
52 Week High
$75.00
$12.05

Technical Indicators

Market Signals
Indicator
KXIN
ADXN
Relative Strength Index (RSI) 70.55 48.25
Support Level $3.51 $7.48
Resistance Level $4.93 $8.90
Average True Range (ATR) 0.88 0.48
MACD 0.05 0.07
Stochastic Oscillator 89.24 51.85

Price Performance

Historical Comparison
KXIN
ADXN

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: